News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IP Group Appoints Professor Lynn Gladden As Non-Executive Director


3/4/2014 9:31:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

4 March 2014 -- IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property based businesses, is delighted to announce the appointment of Professor Lynn Gladden CBE to the Board as Non-executive Director with effect from 26 March 2014.

Professor Gladden is Pro-Vice-Chancellor for Research for the University of Cambridge, the Shell Professor of Chemical Engineering and the former Head of the Department of Chemical Engineering and Biotechnology.

Professor Gladden also serves as a Director of Cambridge Enterprise Limited, is a former member of the Council of the Engineering and Physical Sciences Research Council (EPSRC) and, in 2013, she was appointed to the Shell Science Council. She was Science Advisor to Unilever from 1998 – 2006 and a Senior Consultant to Physical & Engineering Sciences at Unilever from 2006-2008. She is a Fellow of the Royal Society, the Royal Academy of Engineering, the Institution of Chemical Engineers, the Royal Society of Chemistry and the Institute of Physics and is a chartered engineer and chartered chemist.

Professor Gladden leads the activities at the Magnetic Resonance Research Centre at the University of Cambridge and has a particular interest in applying magnetic resonance imaging techniques in the fields of heterogeneous catalysis and multi-phase transport in porous media. She is a Fellow of Trinity College.

She was awarded the 2014 Bakerian Lecture of the Royal Society and, in 2001, the Tilden lectureship and silver medal of the Royal Society of Chemistry. In 1996, she was awarded a Miller Visiting Professorship at the University of California, Berkeley and she received the Beilby Medal and Prize from the Royal Society of Chemistry in 1995. In 2013, Professor Gladden was awarded an Honorary Doctorate of Science from the University of Bristol and in 2009 she was awarded a CBE for services to chemical engineering following an OBE for services to chemistry in 2001.

Alan Aubrey, Chief Executive of IP Group, said: “Professor Gladden has an impeccable track record in academia as well as extensive experience in industry and I am delighted to welcome her to the Board. Her knowledge of both science and business is highly relevant to the IP Group model and will be of huge value to the Group as we continue to expand and grow.”

Professor Gladden said: “Working with university researchers to turn their research insights and breakthroughs into companies will always be both exciting and challenging. IP Group’s philosophy of nurturing and working with scientists and engineers to turn their ideas into businesses creates new opportunities and a stimulating environment to work in which I look forward to being part of.”

IP Group confirms that there is no additional information which is required to be disclosed under Rule 9.6.13 of the Listing Rules of the UK Listing Authority. For more information, please contact:

IP Group plc
www.ipgroupplc.com
Alan Aubrey, Chief Executive Officer
+44 (0) 20 7444 0050
Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0062 / +44 (0) 7979 853 802
liz.vadams@ipgroupplc.com
FTI Consulting
John Dineen, James Melville-Ross
+44 (0) 20 7831 3113
Notes for editors
About IP Group

IP Group is a leading UK intellectual property ("IP") commercialisation company, developing technology innovations primarily from its research intensive partner universities. The Group offers more than traditional venture capital, providing its companies with access to business building expertise, networks, recruitment and business support.

The Company's portfolio comprises holdings in over 70 companies including Oxford Nanopore Technologies, the DNA sequencing development company, Revolymer, best known for its removable chewing gum and Xeros, which has received many accolades for its revolutionary clothes washing techniques with a much reduced requirement for water.

The portfolio includes early stage to mature businesses and has exposure to five main sectors - Energy & Renewables, Medical Equipment & Supplies, Pharma & Biotech, IT & Communications and Chemicals & Materials.

For more information, please visit our website at www.ipgroupplc.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES